Publications

Development of an RNA aptamer as a therapeutic agent for synucleinopathies

 37
Development of an RNA aptamer as a therapeutic agent for synucleinopathies

Tags:

Previous Article

Cognitive symptoms in cerebral palsy from remote network

Next Article

RNA aptamer to treat synucleinopathies

Related Posts

Senescence and tissue fibrosis: opportunities for therapeutic targeting

Senescence and tissue fibrosis: opportunities for thera...

 100

FGF21 reduces ER stress by enhancing the unfolded protein and integrated stress responses through increased sulfide signaling

FGF21 reduces ER stress by enhancing the unfolded prote...

 46

Lentiviral vectors for hematopoietic stem cell gene therapy restore α-globin expression in α-thalassemia red blood cells

Lentiviral vectors for hematopoietic stem cell gene the...

 86